Riskpilot← Back to searchSign inGet full accessVitamin AB
ABActiveOrg 5566403456Ankdammsgatan 20Business and other management consultancy activities · NACE 7020Est. 20030 employees
Revenue 2024
SEK 2,8M
+88% vs 2023
EBITDA margin
34.2%
+613% vs 2023
Equity ratio
55.7%
Financial strength
Net profit 2024
SEK 549K
+1993% vs 2023
| Revenue | SEK 2,8M | +88% |
| EBITDA | SEK 965K | +613% |
| Net profit | SEK 549K | +1993% |
| Total assets | SEK 6,4M | +28% |
| Equity | SEK 3,6M | +11% |
| Employees | 0 | — |
Legal name
Vitamin AB
Org number
5566403456
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
18 mars 2003
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolagets erbjuder affärs- och företagsutveckling samt arbetar med ledarskap och bemannade charterseglingar med därtill hörande utbildnings- och konsulttjänster.
Address
Ankdammsgatan 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 153 | 1 722 | 406 | 1 499 | 2 818 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 683 | −222 | −850 | −188 | 965 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 3 683 | −222 | −850 | −188 | 965 |
| Net financials | −19 | −29 | −11 | −8 | −15 |
| Profit before tax | 2 737 | −52 | −42 | −29 | 701 |
| Tax | −595 | 3 | −0 | −0 | −152 |
| Net profit | 2 142 | −49 | −42 | −29 | 549 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 588 | 6 804 | 4 913 | 4 965 | 6 380 |
| Equity | 3 923 | 3 474 | 3 232 | 3 203 | 3 552 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 923 | 1 788 | 959 | 1 206 | 2 023 |
| Total debt | 2 923 | 1 788 | 959 | 1 206 | 2 023 |
EBITDA margin
34.2%
This company
15.8%
Market median
+116% vs market
20202024
Equity ratio
55.7%
This company
38.2%
Market median
+46% vs market
20202024
Return on equity
15.5%
This company
18.4%
Market median
+16% vs market
20202024
Net profit margin
19.5%
This company
8.1%
Market median
+141% vs market
20202024
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20202024
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitamin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Erik Joakim Ingers | Board of Directors | 0 companies |
| Eva Linnéa Forsén Ingers | Deputy Board Member | 0 companies |
| Anders Jacob Joakim Ingers | Deputy Board Member | 0 companies |